ArticleThe Journal of international medical research2020

HER-2 overexpression is a negative predictive factor for recurrence in patients with non-muscle-invasive bladder cancer on intravesical therapy.

Georgios Moustakas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.